ClinicalTrials.gov record
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
ClinicalTrials.gov ID: NCT00144339
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00144339. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of decline in lung function over time in patients with COPD.
Study identification
- NCT ID
- NCT00144339
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 5,993 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2002 (Type not available)
- Primary completion
- Feb 2008 (Actual)
- Completion
- Not listed
- Last update posted
- May 20, 2014
Started 2002
United States locations
- U.S. sites
- 95
- U.S. states
- 34
- U.S. cities
- 85
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 205.235.3779 Boehringer Ingelheim Investigational Site | Anniston | Alabama | — | — |
| 205.235.3785 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.235.3804 Boehringer Ingelheim Investigational Site | Jasper | Alabama | — | — |
| 205.235.3795 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 205.235.3759 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 205.235.3770 Boehringer Ingelheim Investigational Site | Carmichael | California | — | — |
| 205.235.3778 Boehringer Ingelheim Investigational Site | Escondito | California | — | — |
| 205.235.3810 Boehringer Ingelheim Investigational Site | Lakewood | California | — | — |
| 205.235.3758 Boehringer Ingelheim Investigational Site | Long Beach | California | — | — |
| 205.235.3812 Boehringer Ingelheim Investigational Site | Long Beach | California | — | — |
| 205.235.3773 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 205.235.3800 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 205.235.3802 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 205.235.3786 Pulmonary and Critical Care Medicine | Orange | California | — | — |
| 205.235.3811 Boehringer Ingelheim Investigational Site | Palo Alto | California | — | — |
| 205.235.3741 Boehringer Ingelheim Investigational Site | Rancho Mirage | California | — | — |
| 205.235.3717 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 205.235.3781 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 205.235.3784 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 205.235.3760 Boehringer Ingelheim Investigational Site | Sepulveda | California | — | — |
| 205.235.3711 Boehringer Ingelheim Investigational Site | Stockton | California | — | — |
| 205.235.3764 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 205.235.3783 Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| 205.235.3727 Boehringer Ingelheim Investigational Site | Hartford | Connecticut | — | — |
| 205.235.3808 Boehringer Ingelheim Investigational Site | Hartford | Connecticut | — | — |
| 205.235.3793 Boehringer Ingelheim Investigational Site | Norwalk | Connecticut | — | — |
| 205.235.3815 Boehringer Ingelheim Investigational Site | West Haven | Connecticut | — | — |
| 205.235.3706 Boehringer Ingelheim Investigational Site | Bay Pines | Florida | — | — |
| 205.235.3762 Boehringer Ingelheim Investigational Site | Brandon | Florida | — | — |
| 205.235.3707 Boehringer Ingelheim Investigational Site | Largo | Florida | — | — |
| 205.235.3703 Boehringer Ingelheim Investigational Site | Melbourne | Florida | — | — |
| 205.235.3775 Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| 205.235.3743 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 205.235.3756 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 205.235.3739 Boehringer Ingelheim Investigational Site | West Palm Beach | Florida | — | — |
| 205.235.3719 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 205.235.3790 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 205.235.3716 Boehringer Ingelheim Investigational Site | Augusta | Georgia | — | — |
| 205.235.3794 Boehringer Ingelheim Investigational Site | Stockbridge | Georgia | — | — |
| 205.235.3724 Boehringer Ingelheim Investigational Site | Coeur d'Alene | Idaho | — | — |
| 205.235.3713 Boehringer Ingelheim Investigational Site | Normal | Illinois | — | — |
| 205.235.3768 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 205.235.3749 Boehringer Ingelheim Investigational Site | Dubuque | Iowa | — | — |
| 205.235.3757 Boehringer Ingelheim Investigational Site | Olathe | Kansas | — | — |
| 205.235.3729 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 205.235.3737 Boehringer Ingelheim Investigational Site | Metairie | Louisiana | — | — |
| 205.235.3788 Boehringer Ingelheim Investigational Site | Shreveport | Louisiana | — | — |
| 205.235.3750 Boehringer Ingelheim Investigational Site | Bidderford | Maine | — | — |
| 205.235.3806 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 205.235.3721 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 205.235.3726 354 Birnie Ave | Springfield | Massachusetts | — | — |
| 205.235.3813 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | — | — |
| 205.235.3732 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 205.235.3809 Boehringer Ingelheim Investigational Site | Livonia | Michigan | — | — |
| 205.235.3751 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 205.235.3754 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 205.235.3789 Boehringer Ingelheim Investigational Site | Rochester | Minnesota | — | — |
| 205.235.3734 Boehringer Ingelheim Investigational Site | Chesterfield | Missouri | — | — |
| 205.235.3814 Boehringer Ingelheim Investigational Site | Kansas City | Missouri | — | — |
| 205.235.3747 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 205.235.3763 Boehringer Ingelheim Investigational Site | Lebanon | New Hampshire | — | — |
| 205.235.3797 Boehringer Ingelheim Investigational Site | Cherry Hill | New Jersey | — | — |
| 205.235.3799 Boehringer Ingelheim Investigational Site | Summit | New Jersey | — | — |
| 205.235.3796 Boehringer Ingelheim Investigational Site | Albany | New York | — | — |
| 205.235.3807 Boehringer Ingelheim Investigational Site | Bay Shore | New York | — | — |
| 205.235.3765 Boehringer Ingelheim Investigational Site | Larchmont | New York | — | — |
| 205.235.3748 Boehringer Ingelheim Investigational Site | Mineola | New York | — | — |
| 205.235.3818 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 205.235.3722 Boehringer Ingelheim Investigational Site | Rochester | New York | — | — |
| 205.235.3816 Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| 205.235.3730 Boehringer Ingelheim Investigational Site | Burlington | North Carolina | — | — |
| 205.235.3731 Boehringer Ingelheim Investigational Site | Chapel Hill | North Carolina | — | — |
| 205.235.3736 Boehringer Ingelheim Investigational Site | Durham | North Carolina | — | — |
| 205.235.3745 Boehringer Ingelheim Investigational Site | Elizabath City | North Carolina | — | — |
| 205.235.3712 Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| 205.235.3723 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 205.235.3701 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 205.235.3791 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 205.235.3820 Boehringer Ingelheim Investigational Site | Portland | Oregon | — | — |
| 205.235.3725 Boehringer Ingelheim Investigational Site | Hershey | Pennsylvania | — | — |
| 205.235.3817 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 205.235.3715 Boehringer Ingelheim Investigational Site | Providence | Rhode Island | — | — |
| 205.235.3803 Boehringer Ingelheim Investigational Site | El Paso | Texas | — | — |
| 205.235.3742 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 205.235.3787 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 205.235.3704 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 205.235.3752 Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| 205.235.3744 Boehringer Ingelheim Investigational Site | Danville | Virginia | — | — |
| 205.235.3782 Boehringer Ingelheim Investigational Site | Fredericksburg | Virginia | — | — |
| 205.235.3771 Boehringer Ingelheim Investigational Site | Lynchburg | Virginia | — | — |
| 205.235.3738 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 205.235.3792 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 205.235.3761 Boehringer Ingelheim Investigational Site | Salem | Virginia | — | — |
| 205.235.3718 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 205.235.3780 Boehringer Ingelheim Investigational Site | La Crosse | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 395 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00144339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2014 · Synced Nov 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.